A team of international researchers led by scientists at City of Hope have demonstrated a way to boost thymic function after ...

Building on the lessons learned from the development of the first-and second-generation T cell engagers, Revitope used its deep knowledge of the mechanism of action of immune-based drugs as well ...

There is potential for Tregs and amphiregulin to be used in patients receiving cancer therapies to ameliorate immune function.

These studies indicate that Crohn's disease and ulcerative colitis are heterogeneous diseases characterized by various genetic abnormalities that lead to overly aggressive T-cell responses to a ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

A research team from the University of California, Irvine has revealed a previously unknown mechanism that ... types of injury, cells release the IL-1α protein. It doesn't act on the cell itself ...